The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?
Open Access
- 6 October 2010
- journal article
- perspective
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 26 (3), 441-451
- https://doi.org/10.1002/jbmr.262
Abstract
Over a decade ago, we proposed a “unitary” model for the pathogenesis of osteoporosis that identified estrogen deficiency as the predominant cause of both the early, accelerated, and late slow phases of bone loss in postmenopausal women and as a contributing cause of the continuous phase of bone loss in aging men. While this was a plausible model then, new data over the intervening years suggest a need to modify these concepts. Indeed, based largely on rodent studies, a “revisionist” view of the pathogenesis of osteoporosis has been proposed recently that attempts a paradigm shift from the estrogen-centric model to one in which bone loss is largely independent of estrogen deficiency and is driven instead by cell-autonomous age-related factors. However, detailed clinical investigative studies using quantitative computed tomography demonstrate that the onset of cortical bone loss in humans is closely tied to estrogen deficiency; thus the estrogen-centric view is likely correct for cortical bone, which comprises over 80% of the skeleton and is the major structural determinant of fracture risk at most skeletal sites. By contrast, these same studies also demonstrate that trabecular bone loss begins in sex hormone–replete young adults of both sexes. This suggests that a significant proportion of trabecular bone loss is either estrogen-independent or, as suggested by some studies, requires higher levels for its regulation. In this perspective, we critically review these and other findings, leading us to conclude that our original model requires modification but not revision. © 2011 American Society for Bone and Mineral Research.Keywords
This publication has 105 references indexed in Scilit:
- Regulation of circulating sclerostin levels by sex steroids in women and in menJournal of Bone and Mineral Research, 2010
- Effects of Suppression of Follicle-Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2010
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- Effects of chronic estrogen treatment on modulating age-related bone loss in female miceJournal of Bone and Mineral Research, 2010
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2010
- Osteoporosis in MenEndocrine Reviews, 2008
- Building bone to reverse osteoporosis and repair fracturesJCI Insight, 2008
- Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activationProceedings of the National Academy of Sciences of the United States of America, 2007
- Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex SteroidsJournal of Biological Chemistry, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006